Mass Spectrometry Cluster Verification for Disease Pathway Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current clustering algorithms for mass spectrometry data struggle with high dimensionality, failure to consider multiple algorithms, and determining meaningful results, particularly in identifying biological pathways or disease indicators, leading to challenges in verifying the significance of co-clustering outcomes.
Innovation Solution
The system applies multiple clustering algorithms, such as PCA-PCVG and K-means, to mass spectrometry data, identifies co-clustered groups, and reanalyzes the data with additional compounds to quantify co-occurrence, using a DIA method to verify the relationship of compounds to biological processes without reacquiring samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If clustering algorithms are applied to high-dimensional mass spectrometry data, then compound groups can be identified, but the results lack verification of biological significance
Solution Approach 1:
The system performs iterative verification by taking compounds identified through clustering, checking their co-occurrence in biological pathways, and using this feedback to refine and verify the clustering results. This closed-loop approach ensures that identified compound groups are not only statistically clustered but also biologically meaningful.
Solution Approach 2:
The system pre-loads and prepares pathway data, compound databases, and biological knowledge bases before performing clustering analysis. This preliminary preparation allows for rapid verification of clustering results against known biological pathways without requiring additional experimental data collection.
2Reliability
If multiple clustering algorithms are used to improve result reliability, then the analysis becomes more robust, but the computational complexity and time increase
Solution Approach 1:
The system applies multiple clustering algorithms but focuses verification efforts on the most promising results. Rather than exhaustively verifying all possible cluster combinations across all algorithms, the system identifies key candidate clusters and performs targeted verification, reducing overall processing time while maintaining reliability.
Solution Approach 2:
The system combines results from multiple clustering algorithms by identifying compounds that consistently appear together across different algorithms. This merging approach consolidates the strength of multiple methods while reducing the need to process every possible cluster configuration separately.
3Reliability
If additional compounds from biological pathways are included to verify clustering, then biological relevance improves, but the data dimensionality and processing complexity increase
Solution Approach 1:
The system extracts only the necessary pathway information and compound relationships needed for verification, rather than processing entire pathway databases. By extracting specific co-occurrence patterns and biological relationships relevant to the clustered compounds, the system reduces processing complexity while maintaining verification power.
4Measurement precision
If co-occurrence analysis is performed to verify compound groups, then false positives are reduced, but the computational requirements and analysis time increase
Solution Approach 1:
The system performs co-occurrence analysis locally and selectively, focusing computational resources on verifying specific compound groups that show promise from initial clustering. Rather than computing co-occurrence for all possible compound combinations across the entire dataset, the system targets analysis at relevant local regions of the data space.
Data Source
AI summary
A mass range is fragmented and mass analyzed using n samples, producing measurements in n dimensions. Two clustering algorithms are applied to the measurements, producing two sets of clusters, and compounds in the sets are identified. Two or more compounds found in a cluster of both sets are identified. The two or more compounds are compared to groups of compounds related to a biological process to identify a group that includes the two or more compounds. An additional compound is selected from the group. The two sets are reanalyzed to identify the compound in the sets. A co-occurrence matrix is calculated that quantifies the co-occurrence of the compound and each of the two or more compounds in the sets. If no co-occurrence quantity for the compound and each of the two or more compounds in the matrix is below a threshold, the two or more compounds are verified.